Discontinued — last reported Q4 '24
Johnson & Johnson Consumer Health — Litigation expense decreased by 95.0% to $100.00M in Q4 2024 compared to the prior quarter.
jnj_segment_consumer_health_litigation_expense| Q2 '21 | Q3 '21 | Q4 '21 | Q2 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $100.00M | $1.40B | $100.00M | $100.00M | $6.90B | $6.90B | $100.00M | $2.70B | $300.00M | $2.00B | $100.00M |
| QoQ Change | — | >999% | -92.9% | +0.0% | >999% | +0.0% | -98.6% | >999% | -88.9% | +566.7% | -95.0% |
| YoY Change | — | — | — | +0.0% | >999% | — | +0.0% | -60.9% | +200.0% | — | — |